Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06675240 · ClinicalTrials.gov registry record · NA
Meditative Neurofeedback for Depression
A NA study of Depression - Major Depressive Disorder and Depression Disorders, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT06675240: Recruiting NA study of Depression - Major Depressive Disorder and Depression Disorders, sponsored by University of California, San Diego.
NCT06675240 is a NA study of Depression - Major Depressive Disorder and Depression Disorders that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 27 participants, below the 101-participant average among 19 other Depression - Major Depressive Disorder trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06675240, a NA study of Depression - Major Depressive Disorder and Depression Disorders, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this open-label single-arm study is to test a meditative neurofeedback intervention for depressed mood.
Primary Outcome
Depression Symptoms on the Patient Health Questionnaire 9-item (PHQ9) scale, min 0 max 27 with lower scores representing better outcome
Conditions Studied
Interventions
- BEHAVIORAL MediNF
Study Locations (1)
California
- University of California San Diego - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2024-11-15 |
| Est. Completion | 2027-06-15 |
| Phase | NA |
What NCT06675240 shows while recruiting
NCT06675240 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 101-participant average among 19 other Depression - Major Depressive Disorder trials with a reported enrollment target (73% lower).
The record links to 2 conditions, with Depression - Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which MediNF is the first listed.
NCT06675240 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06675240 about?
NCT06675240 is a clinical study titled "Meditative Neurofeedback for Depression". The goal of this open-label single-arm study is to test a meditative neurofeedback intervention for depressed mood.
What is the current status of trial NCT06675240?
This trial is currently recruiting. It is a NA study. The enrollment target is 27 participants. The study started on 2024-11-15. Estimated completion is 2027-06-15.
What conditions does trial NCT06675240 study?
This clinical trial studies the following conditions: Depression - Major Depressive Disorder, Depression Disorders.
What interventions are being tested in trial NCT06675240?
The interventions under investigation include: MediNF (BEHAVIORAL).
Who is sponsoring clinical trial NCT06675240?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06675240 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression - Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06675240's enrollment target sits among peer trials
27 18th of 19 higher than 2 of 19 other Depression - Major Depressive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression - Major Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Mindful Self-Compassion to Address PTSD and Substance Use in Unhoused Women
RECRUITING · NA
-
Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
RECRUITING · NA
-
Virtual Reality-Enhanced Behavioral Activation for Older Adults With Depression
RECRUITING · NA
-
Behavioral Health Collaborative Care Model in Post-ICU Clinic Family Pilot
RECRUITING · NA
-
Combining rTMS & Aerobic Exercise to Treat Depression and Improve Post-Stroke Walking
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI